Skip to content
Search

Latest Stories

Ensure patient consent is sought for Covid-19 jabs, PDA reminds pharmacists

The Pharmacists Defence Association (PDA) has released a brief guidance for community pharmacies to ensure that necessary consent is obtained from the person prior to administering the Covid-19 vaccination.

The association’s guidance came as the process of granting consent is of paramount importance, as to do so without would be technically classified as an assault.


“As stated in the Covid-19 standard operating procedures, there is no legal requirement for consent to immunisation to be in writing and a signature on a consent form is not conclusive proof that consent has been given, but serves to record the decision and the discussions that have taken place with the patient or the person giving consent on a child’s behalf,” the PDA pointed out.

As consent for Covid-19 vaccination plays a major role in the vaccination drive, the PDA therefore compiled a brief guide to assist community pharmacists with ensuring that suitable consent is obtained prior to administering the virus jabs...

  1. Time: Allow the patient time to think and consider whether they wish to proceed with the procedure. If for any reason they cannot have the vaccination on a given day, if possible, give them the opportunity to attend an appointment at a later date.
  2. History taking: Be sure to take as full a patient medical and social history as is required to ensure any material risks to the patient are identified. Ensure all questions are fully completed and clarify any unclear answers, to allow consideration of an alternative vaccination should the Summary of Product Characteristics for a particular one list an absolute contraindication.
  3. Record keeping: All documentation must be fully completed and any discrepancies clarified before commencing with the vaccination. Any omitted data can potentially lead to adverse outcomes for patients so full record-keeping is of paramount importance. For example, it is vital that information is gathered as to whether a patient has had any other vaccinations in the 7 days prior to receiving the Covid-19 vaccine, as this would preclude them from receiving it at the first instance.
  4. Patient information leaflets: Must be provided post-vaccination, along with post-vaccination record cards. The purpose of patient information leaflets is to make patients aware of any possible side effects they may experience and to give them an additional understanding of what they are being vaccinated with. The leaflets also contain key information to remind patients on steps to take for effective aftercare.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less